Pliant Therapeutics, Inc.PLRXNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank88
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
17.47%
↑ 111% vs avg
Percentile
P88
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-155.49%
Historical baseline
PeriodValue
202517.47%
2024-33.64%
2023-22.96%
2022-25.43%
2021-102.42%
2020-1255.31%
201990.29%
2018-67.38%
20170.00%